ORLANDO – When asked if the company has an overarching theme as it prepares to open its booth here at HIMSS24 on Tuesday, Kathleen Aller, head of global healthcare market strategy at InterSystems, said: answered simply: It becomes possible. ”
This goal is easy to explain but very complex to achieve. Anyone who has followed the company and all the work it has done over 40 years to connect organizations in all corners of the healthcare ecosystem will be familiar with it.
“Interoperability has been, and continues to be, our foundation,” says Aller. “We deliver interoperability at scale.”
And all the work that has been done over the past 40 years to lay the foundation for seamlessly delivering the right data to the right people at the right time is perhaps even more important today. Masu. More than ever.
“If you look at where the industry is going and where artificial intelligence is going, you can’t do AI if the data isn’t ready, if the data isn’t comprehensive,” she said. Ta. “You need technology to manage that, and we have the technology. You need to build AI solutions and incorporate them into healthcare applications. And we’re doing it.”
In addition to supporting AI initiatives, InterSystems has several other key priorities that it plans to highlight at HIMSS24.
Chief among them is interoperability mandates for health plans, with CMS rules requiring application programming interfaces to exchange data between payers.
“This is a big problem in the United States,” Aller said. “APIs are one part of that. But APIs are the easy part. APIs are going to have a long-term record that mandates assume. I believe it’s going to be important to have that in place in order for people to have the rules they have in place, the operational changes needed in 2026 and the API implementations needed in 2027. We will comply with the changes and continue to enhance them thereafter. ”
Aller said InterSystems will also focus on innovation efforts with various healthcare organizations, noting that the company’s platform is “built by Epic, built by VA, built by 3M.” .
It’s also being built by “a lot of young businesses, many of which will be featured at our booth and we encourage people to come and meet them,” she said. Told.
One of these companies has developed a device that fits over teeth and monitors health status through saliva. Another is to use this technology to help match patients to clinical trials, allowing patients to choose to share their data and participate in clinical trial networks. “There are other people working on genomics.”
VA plans to showcase some of its own interoperability use cases with InterSystems, as well as eHealth Exchange, and “to demonstrate what we’re doing with QHIN and use cases for FHIR on a national scale.” We talk a lot about the work we’re doing.” ”
As always, InterSystems will be a key part of this formidable interoperability showcase. We are part of HL7’s long-standing participation in the DaVinci project, designed to accelerate the expansion of FHIR across the industry, and are joined by Michael Marchant of UC Davis and Russ Leftwich of InterSystems and HL7’s It will be a joint presentation, and Keegan from Point of Care Partners, who is managing the Jocelyn Da Vinci project, will also be at the booth.”
InterSystems is displaying several educational sessions outside its booth, including “GenAI’s Got Talent – Can It Save Healthcare?” It was previewed here.
The other will be moderated by Jennifer Goldsack, CEO of the Digital Medicine Society, and will focus on “talking about digital health innovation beyond AI.” As part of the panel discussion, clinical research organization Metadata Solutions will share what they are doing to “obtain real-world evidence electronically,” and 3M Health will share “what they are doing. We’re going to talk about some things, and Jen is going to talk about kind of “integrating that within the framework of digital health.” ”
The third major session, which is by invitation only but invitations may be requested, is a payer-focused luncheon focused on “Regulation as a Catalyst for Health Plan Innovation and Health Plan Strategy.” Mr. Aller said. Enter Dominick Bizzarro, Chief Strategy Officer of MVP Health (and former Managing Director of InterSystems Health Share).
“He takes an agile approach to strategic planning that builds on what federal and state regulators are doing and how to incorporate that and change the whole approach to regulation to say, “We have to check that box.” Rather, we need to have a long-term plan so that we can achieve compliance while also achieving our long-term goals. ” Aller explained.
In terms of new products and announcements, InterSystems has several announcements.
“We have just launched the InterSystems Payer Solution on our website to address new interoperability and preauthorization requirements.
“And we also talk about our National Gateway service, which is kind of one connection to QHIN, Carequality and CommonWell through kind of a one-stop shop.”
We will also focus on the research data pipeline, which is the FHIR-based feed to the OMOP research data model.
Aller says she is just looking forward to the conversations with customers, clients and other HIMSS24 attendees.
“One of the challenges of being InterSystems is that we have a wide range of positions, so we serve the people who are building the solutions, the people who are providing the care, and the people who are paying for the care. One of the conversations that we’re going to have is that we’re: We’re: We’re: We’re: We’re: We’re: We’re: We’re: We’re: We’re: We’re: We’re going to have a conversation with you about genAI, and where we’re going with genAI, and how best to use genAI. Crowdsource.
“We have a survey that we have conducted at several other events and will be conducting at HIMSS as well. We encourage you to participate and share your views,” she added.
“One of the data points we noticed was when we asked people what the biggest risk from Gen AI was, the issue of patient data being released into the public domain without consent or unintentionally. Or both.
“I looked at a survey of about 134 respondents and 45% said that was their biggest concern. So that’s one of the things I want to talk to people about. “Do we mitigate it? What does that mean? We have to think from a product perspective, from a governance perspective. What do we do with it? What does that mean for our future?” Will it have any impact?”
InterSystems will be at HIMSS24, booth #1361.
